Search WINT
WINDTREE THERAPEUTICS INC /DE/
OTC · CIK 946486
Last close0
Daily change+0.00 (0.00%)
10 Years gain-100.00%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
WINT · STANDARD
SIC 2836 · Biological Products, (No Diagnostic Substances) · Fiscal year end 1231
Fundamental
19.1Momentum
n/aAcceleration
n/aConfidence
64.0Annual Revenue8
Quarterly Revenue32
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet5.6 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Key Metrics
Revenue Growth TTM-70.69%OK
Revenue CAGR 3Y-54.06%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 FY Dec 31, 2024 | n/a | $0.00 | -$26.14M | -$15.40M | -$15.41M | n/a | n/a | n/a | -566.6% | n/a |
| 2024 FY Dec 31, 2023 | n/a | $0.00 | -$20.60M | -$13.44M | -$13.45M | n/a | n/a | n/a | -1,117.56% | n/a |
| 2023 FY Dec 31, 2022 | n/a | $0.00 | -$41.33M | -$19.45M | -$19.47M | n/a | n/a | n/a | -279.41% | n/a |
| 2022 FY Dec 31, 2021 | n/a | $0.00 | -$77.28M | -$23.66M | -$23.94M | n/a | n/a | n/a | -169.22% | n/a |
| 2021 FY Dec 31, 2020 | n/a | $0.00 | -$30.32M | -$25.32M | -$25.61M | n/a | n/a | n/a | -45.63% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $502,000.00 | sum latest 4 fiscal quarters Revenue | OK | 0001437749-20-006970, 0001437749-19-022959 |
| Revenue Growth TTM | -70.69% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-20-006970, 0001437749-19-022959 |
| Revenue CAGR 3Y | -54.06% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001437749-20-006970 |
| Revenue CAGR 5Y | -41.28% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001437749-20-006970 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001437749-19-022959 |
| Current Ratio | 0.32x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0x | (Cash + Short-term Investments) / Total Debt | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |